-
Akira S, Takeda K. Toll-like receptor signalling[J]. Nat Rev Immunol, 2004, 4(7): 499-511. doi: 10.1038/nri1391
-
Alter H J, Seeff L B. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome[J]. Semin Liver Dis, 2000, 20(1): 17-35. doi: 10.1055/s-2000-9505
-
Auffermann-Gretzinger S, Keeffe E B, Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection[J]. Blood, 2001, 97(10): 3171-3176. doi: 10.1182/blood.V97.10.3171
-
Beasley R P, Hwang L Y, Lin C C. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan[J]. Lancet, 1981, 2(8256): 1129-1133.
-
Bigger C B, Guerra B, Brasky K M. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees[J]. J Virol, 2004, 78(24): 13779-13792. doi: 10.1128/JVI.78.24.13779-13792.2004
-
Bröring R, Wu J, Men Z, et al. 2008. Toll-like receptor stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. J Hepatol, in press.
-
Foy E, Li K, Sumpter R Jr. Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-Ⅰ signaling[J]. Proc Natl Acad Sci USA, 2005, 102(8): 2986-2991. doi: 10.1073/pnas.0408707102
-
Gorczynski R M, Hozumi N, Wolf S. Interleukin 12 in combination with anti-interleukin 10 reverses graft prolongation after portal venous immuni-zation[J]. Transplantation, 1995, 60(11): 1337-1341. doi: 10.1097/00007890-199512000-00024
-
Groux H, O'Garra A, Bigler M. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis[J]. Nature, 1997, 389(6652): 737-742. doi: 10.1038/39614
-
Guidotti L G, Ishikawa T, Hobbs M V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes[J]. Immunity, 1996, 4(1): 25-36. doi: 10.1016/S1074-7613(00)80295-2
-
Guidotti L G, Rochford R, Chung J. Viral clearance without destruction of infected cells during acute HBV infection[J]. Science, 1999, 284(5415): 825-829. doi: 10.1126/science.284.5415.825
-
Helbig K J, Lau D T, Semendric L. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector[J]. Hepatology, 2005, 42(3): 702-710. doi: 10.1002/(ISSN)1527-3350
-
Hiasa Y, Horiike N, Akbar S M. Low stimulatory capacity of lymphoid dendritic cells expressing hepatitis C virus genes[J]. Biochem Biophys Res Commun, 1998, 249(1): 90-95. doi: 10.1006/bbrc.1998.9089
-
Kato T, Mizokami M, Orito E. High prevalance of TT virus infection in Japanese patients with liver diseases and in blood donors[J]. J Hepatol, 1999, 31(2): 221-227. doi: 10.1016/S0168-8278(99)80217-7
-
Kimura K, Kakimi K, Wieland S. Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice[J]. J Immunol, 2002, 169(9): 5188-5195. doi: 10.4049/jimmunol.169.9.5188
-
Knolle P A, Gerken G. 2000Local control of the immune response in the liver. Immunol Rev, 174: 21-34.
-
Li K, Foy E, Ferreon J C. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF[J]. Proc Natl Acad Sci U S A, 2005, 102(8): 2992-2997. doi: 10.1073/pnas.0408824102
-
McCormick C J, Challinor L, Macdonald A. Introduction of replication-competent hepatitis C virus transcripts using a tetracycline-regulable baculovirus delivery system[J]. J Gen Virol, 2004, 85(Pt 2): 429-439.
-
McHutchison J G, Fried M W. Current therapy for hepatitis C: pegylated interferon and ribavirin[J]. Clin Liver Dis, 2003, 7(1): 149-161. doi: 10.1016/S1089-3261(02)00077-6
-
O'Neill L A. TLRs: Professor Mechnikov, sit on your hat[J]. Trends Immunol, 2004, 25(12): 687-693. doi: 10.1016/j.it.2004.10.005
-
Racanelli V, Rehermann B. The liver as an imm-unological organ[J]. Hepatology, 2006, 43(2 Suppl 1): S54-S62.
-
Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection[J]. Nat Rev Immunol, 2005, 5(3): 215-229. doi: 10.1038/nri1573
-
Robek M D, Wieland S F, Chisari F V. Inhibition of hepatitis B virus replication by interferon requires proteasome activity[J]. J Virol, 2002, 76(7): 3570-3574. doi: 10.1128/JVI.76.7.3570-3574.2002
-
Sobao Y, Tomiyama H, Sugi K. The role of hepatitis B virus-specific memory CD8 T cells in the control of viral replication[J]. J Hepatol, 2002, 36(1): 105-115. doi: 10.1016/S0168-8278(01)00264-1
-
Steinbrink K, Wolfl M, Jonuleit H. Induction of tolerance by IL-10-treated dendritic cells[J]. J Immunol, 1997, 159(10): 4772-4780.
-
Sumpter R Jr, Loo Y M, Foy E. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I[J]. J Virol, 2005, 79(5): 2689-2699. doi: 10.1128/JVI.79.5.2689-2699.2005
-
Sun Z, Wada T, Maemura K. Hepatic allograft-derived Kupffer cells regulate T cell response in rats[J]. Liver Transpl, 2003, 9(5): 489-497. doi: 10.1053/jlts.2003.50091
-
Wesche H, Henzel W J, Shillinglaw W. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex[J]. Immunity, 1997, 7(6): 837-847. doi: 10.1016/S1074-7613(00)80402-1
-
Wieland S F, Spangenberg H C, Thimme R. Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees[J]. Proc Natl Acad Sci U S A, 2004, 17; 101(7): 2129-2134.
-
Wu J, Lu M, Meng Z, et al. 2007. TLR-mediated control of HBV replication by non-parenchymal liver cells in mice. Hepatology, in press.